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Background. The surgical removal of heel spur (HS) provokes many controversial opinions, but clinical
studies show the risk of complication after operation. An alternative to the surgical removal of HS is Extracorporeal
Shock Wave Therapy (ESWT), because it is non-invasive method.
Objective. The aim of the study is to compare the short-term analgesic effects of ESWT and conservative
treatment (CT) in males with chronic HS.
Methods. Sixty patients (mean age 54.9±4.3 years; range 42 to 59 years) were examined who had pain
associated with HS. In the shockwave group (group 1) patients received 1000–2000 impulses of shocks to the
affected heel in a single session. The patients in this group took a series of 5 ESWT in 1 week intervals.
Patients in the control group (group 2) at the same time received CT consisting of nonsteroidal anti-inflammatory
drugs (NSAIDs), orthotics and a local cortisone injection. The basic method of research was to evaluate pain
according to Visual Analogue Scale (VAS) 0–10. The patients of the two groups were tested before the treatment,
after the last treatment and 3 months and 6 months after the treatment.
Results. A significant decrease of VAS (p=0.000) was seen in the shockwave group. In the control group
no significant decrease of VAS was seen.
Conclusions. ESWT reduces pain more effectively than CT in men with chronic HS.
KEY WORDS: extracorporeal shock wave therapy, conservative treatment, visual analogue scale, heel
spur, pain.
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Introduction
Chronic inflammation of the plantar fascia, in the
place of its connection to calcaneal tuberosity, can
be a major cause of pain in the adult population.
Due to a visible X-ray imaging calcification – bone
spurs near the heel – the condition is commonly
called “heel spur” (HS). Among other causes of the
condition, there are: an inflammation of the Achilles
tendon associated with inflammation of the Achilles
tendon bursitis, inflammation of adipose tissue
beneath calcaneal tuberosity by repeated micro
damages that cause degeneration of the tissue,
fatigue fractures of the calcaneal tuberosity, neuro-
pathy caused by pressure on the plantar branch of
the tibial nerve by an overgrown plantar aponeurosis.
Risk factors also include excessive body weight,
running and jumping, work that entails standing or
lifting heavy objects, flat feet, rheumatic changes [1–
5]. Originally, the condition may be asymptomatic –
pain rarely occurs in the early stages of the condition.
Most patients come to the doctor in a fairly advanced
stage of the condition, complaining on severe pain
in the heel that escalates after they walk on hard
ground or carry heavy objects and that usually
disappear after they rest.
The treatment of HS and plantar fascia provokes
many controversial opinions, many authors point to
the need for surgical removal of calcaneal bursitis
and resection of HS, but clinical studies show the
risk of complication after operation [6–12]. An
alternative to the surgical treatment of HS is CT that
involves the use of physiotherapy treatments, such
as ionophoresis, laser, ultrasound, and recently more
and more often ESWT is used [13–16].
ESWT is a very effective method which effec-
tiveness is comparable to surgery. The most impor-
tant is the fact that it is a completely non-invasive
method. It has not yet been fully explained how it
works exactly, but it probably involves micro de-
structions – the application of ESWT causes micro
breaks in avascular or poorly-vascularized tissue
thus stimulating appropriate revascularization and
stem cell growth. Patients may continue to work or
train the next day. Given the significant reduction of
activity limitations and short duration of the treatment,
P.  Lizis
International Journal of Medicine and Medical Research
2015, Volume 1, Number 1, p. 21-26
copyright © 2015, TSMU, All Rights Reserved
22
S
U
R
G
IC
A
L
D
IS
E
A
S
E
S
IJMMR 2015 Vol. 1 No. 1
ESWT is not only comparable to surgical treatment,
but, in general, it is also less expensive than a few
months of CT [17–18].
The aim of the study was to compare the short-
term analgesic effects of ESWT and CT in males
with chronic HS.
Methods
Continuous research was carried out in the
period from January 2010 to July 2012, and involved
sixty patients (middle age 54.9±4.3 years; range from
42 to 59 years) who had pain associated with HS.
The average BMI was 24.29±0.78. None of the men
was obese. The study was conducted in Busko-Zdroj
Spa. The patients had unilateral pain. The average
duration of pain was 15.2±5.3 months. Inclusion
criteria were pain over the X-ray examined HS,
unsuccessful CT (iontophoresis, cryotherapy, laser
therapy, ultrasound and phonophoresis) during the
six months before referral to Spa in Busko-Zdroj.
Exclusion criteria were arthritis (rheumatoid arthritis,
spondarthritis, crystal induced arthropathies) diabe-
tes mellitus, neurological abnormalities, age under
18 years, infectious or tumorous diseases, skin
ulcerations, and bursitis. All patients were informed
about the principles of the treatment, and they signed
a written permission for treatment and participation
in the study.
In the shockwave group (group 1) patients
received – during the first treatment 1000 impulses,
1500 impulses in the second, and 2000 impulses in
the third, fourth and fifth treatment (the pressure of
2.5 bar, the frequency of 8 Hz, the energy density of
0.4 mJ/mm2). The patients in the shockwave group
took a series of 5 ESWT in 1 week intervals.
Apparatus BTL-5000 SWT was used for the treat-
ment. The active engagement between the head of
the apparatus with a diameter of 15 mm and skin
was gel used in ultrasound scan. The procedure was
performed in the area of most intense pain –
calcaneal tuberosity. Treatment time did not exceed
10 minutes. Patients in the control group (group 2)
at the same time received CT consisting of NSAIDs,
orthotics and a local cortisone injection with 0.5 mL
of betamethasone (7 mg/mL).
The basic method of research was to evaluate
pain according to VAS, where  0 – no pain; 10 –
severe (maximum) pain at rest, after walking on
awakening, and after normal daily activity. The
patients of two groups were tested before the
treatment, at the end of the last treatment. The
patients were also examined for 3 months and 6
months after the end of treatment. The results obser-
ved were classified as excellent improvement (a VAS
reduction of over 50 %), good improvement (a VAS
reduction of over 30 % to 50 %), slight improvement
(a VAS reduction of over 15 % to 30 %).
In order to evaluate the early results of the
treatment, the obtained data was subjected to
statistical analysis. The statistical distributions of the
analyzed characteristics were examined by the use
of Kolmogorov-Smirnov’s test. It was shown that the
tested variables had normal distribution. Basic
descriptive statistics was used for the analysis. The
mean arithmetic (x) and standard deviation (SD)
of the studied traits of men in both groups were
calculated. In order to evaluate the statistical
significance of differences in the intensity of pain
before the treatment, after the last treatment and 3
and 6 months later, while at rest, while walking on
awakening, and after normal daily activity, one-way
analysis of variance (ANOVA) was used in both
studied groups. The value of the function F Snedecor
was observed in various combinations. The statistical
significance of differences in the intensity of pain was
assessed at the 0.05 level. Calculations were
performed at the Department of Computer Science
at Holy Cross University in Kielce with the use of
MedCalc software – version 11.4.3.0, licensed to
Holy Cross College. The research project was
authorized by the Bioethics Committee at Holy Cross
College in Kielce, resolution 1/10/KB dated
29.01.2010.
Results
A significant decrease of VAS (p = 0.000) was
seen in the shockwave group (group 1) just after the
end of ESWT and in the period after the end of ESWT
3 months later and in the period from 3 months to 6
months after the end of ESWT at three reference
points – at rest, when walking on awakening, and
after normal daily activity. No significant decrease
of VAS was seen in the control group (group 2) just
after the end of CT at rest  (p=0.202), when walking
on awakening (p=0.367) and after normal daily
activity (p=0.341). No significant decrease of VAS
was seen in the period after the end of CT 3 months
later at rest (p=0.367), when walking on awakening
(p=0.630) and after normal daily activity (p=0.633).
Also, no significant decrease of VAS was seen in
the period from 3 months to 6 months after the end
of CT at rest (p=0.608), when walking on awakening
(p=0.337) and after normal daily activity (p=0.393).
Studies have shown that ESWT reduces pain more
effectively than CT in males with chronic HS
(Table 1).
The analgesic efficacy of ESWT is confirmed
by the detailed analysis of differences in the
frequency of occurrence of pain intensity between
groups. In the shockwave group (group 1) excellent
improvement (a VAS reduction of over 50 %) was
seen in 22/30 (73.3 %) patients, good improvement
(a VAS reduction of over 30 % to 50 %) was seen in
6/30 (20 %) patients and slight improvement (a VAS
P.  Lizis
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Table 1. The intensity of pain (VAS)  in the following terms of research at three reference points
	

						
 		
 		 	
	
  !" #$	 $	  !" #$	 $	  !" #$	 $	

%			&'

(		


	

&'


)*+!,*-


.*/!,*) .-*,))0 ,*,,,
/*1!,*-


2*!,*/ ,,*1/0 ,*,,,
/*.!,*-


2*3!,*) 33*,))0 ,*,,,

(		


	

&'

1

	&'


.*/!,*)


1*-!,*/ -.*/+0 ,*,,,
2*!,*/


+*+!,*2 /2*),,0 ,*,,,
2*3!,*)


+*2!,*) )/*12)0 ,*,,,

1

	&'

2

	&'


1*-!,*/


3*.!,*) .3*,1.0 ,*,,,
+*+!,*2


1*,!,*) 2-*)20 ,*,,,
+*2!,*)


1*.!,*2 +3*),20 ,*,,,
43

%		

		
		

(		


		
		



/*+!,*-



/*!,*- *22) ,*3,3
/*2!,*-



/*+!,*/ ,*/3/ ,*12)
/*)!,*-



/*.!,*) ,*-31 ,*1+

(		


		
		

1
	

		
		



/*!,*-



/*1!,*/ ,*/3/ ,*12)
/*+!,*/



/*.!,*/ ,*31+ ,*21,
/*.!,*)



/*2!,*- ,*31 ,*211

1
	

		
		

2
	

		
		



/*1!,*/



/*+!,*) ,*32. ,*2,/
/*.!,*/



/*)!,*/ ,*-1) ,*11)
/*2!,*-



/*/!,*- ,*)+ ,*1-1

reduction of over 15 % to 30 %) was seen  2/30
(6,7 %) patients at three reference points – at rest,
when walking on awakening, and after normal daily
activity.  There was no decreasing in pain intensity
in the control group (group 2), as it was unchanged
in 24/30 (80 %) patients and worsened in 6/30 (20 %)
patients at these points (Table 2).
Discussion
HS is a condition that affects more and more
people of all ages. It affects their quality of life,
reduces socio-professional activity and becomes the
cause of frequent sickness absence. The effecti-
veness of treatment for HS causes many con-
troversial opinions. There is no consensus on how
P.  Lizis
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to treat it, conservatively or surgically. Endoscopy is
used most often in surgical treatment. This method
is cost-effective, non-invasive, with low risk of post-
surgery complications and allows patients to return
to socio-professional activity after surgical treatment
earlier [8, 19–22]. An alternative to surgical treatment
is to use ESWT for treatment of chronic heel spur.
There are different opinions on this subject, but the
prevalent  among them are views highlighting the
analgesic efficacy of ESWT in the treatment of
chronic HS. The analgesic success of ESWT
probably depends on the total dose of energy, not
on the density of stream of emitted energy [18, 23–
25]. Review of subject literature shows that the
analgesic efficacy of ESWT with different physical
characteristics and over a different period of time
concerning was investigated. Hammer, Adam,
Kreutz, Kohn, Seil [14] assessed the analgesic
efficacy of ESWT in patients with painful chronic
inflammation of the plantar fascia. Patients treated
with ESWT were given 3000 impulses of shocks with
energy density of 0.2 mJ/mm2 at weekly intervals.
Two years after the end of treatment the level of
pain on a VAS scale in patients treated with ESWT
decreased 94 %. In subsequent studies, the pre-
viously mentioned authors used medical ultrasono-
graphy to assess the effects of ESWT on changes
in thickness of plantar fascia that had been affected
by chronic inflammation. During the treatment, 3
sessions of 3000 shock wave impulses with the
stream density of 0.2 mJ/mm2 were applied at weekly
intervals. The thickness of plantar fascia was
measured 2 cm distally to calcaneal tuberosity. In
addition, the level of pain was recorded in the VAS
scale. The ultrasound scan 6 months after the end
of ESWT showed a significant reduction in the
thickness of plantar fascia of the affected foot and
the level of patients pain was reduced 79 % in the
VAS scale [26]. Metzner, Dohnalek, Aigner [18] also
used ESWT in patients with chronic plantar fascia.
Each patient received 1000 impulses of shock wave,
the density of energy stream was 0.35 mJ/mm2. The
patients were examined 6 weeks, 16 months and
72 months after the end of ESWT. It turned out that
pain was reduced  in 81% of patients after 6 weeks,
in 88 % of patients – after 16 months, and in 96 % of
patients in the last examination – 72 months after
the end of ESWT. Based on these results, the
authors concluded that the applied doses of ESWT
effectively reduced pain and the achieved therapeutic
effects provide satisfactory long-term results. Yalin,
Keskin Akca, Selcuk, Kurtaran, Akyuz [27] used
ESWT for analgesic purposes in patients with HS
and treated them for 5 weeks with 2000 impulses of
shock waves, ranging from 0.05 to 0.4 mJ/mm2.
Clinical results demonstrated excellent results (no
pain) in 66.7 % of the cases, good                       results
(50 % of pain reduced) in 15.7 % of the cases, and
unsatisfactory outcome (no reduction in pain) in 17.6
% of all cases. At the same time, the study showed
no correlation between the reduction of pain and a
significant modification of the HS in X-ray picture.
Moretti, Garofalo, Patella, Sisti, Corrado, Mouhsine
[28] evaluated the analgesic efficacy of low doses of
ESWT for foot plantar fascia inflammation
accompanying HS in runners – athletes. The
subjects received a weekly shock wave of 1000
impulses, 0.06 mJ/mm2 energy density. ESWT con-
tinued for four weeks. The patients were examined
after the last session of ESWT. Clinical results were
excellent in 59 % of cases, good in 12 % of cases,
satisfactory in 21 % and clearly unsatisfactory in 8 %.
Ultrasound examination after the end of ESWT
showed the disappearance of inflammatory symp-
toms in 61 % of athletes.
Cosentino, Falsetti, Manca, De Stefano, Frati,
Frediani  et al. [29] evaluated the analgesic efficacy
ESWT at patients with calcaneal enthesophytosis.
Patients were randomly assigned into two equal
groups. The shockwave group (group 1) received
six treatments (one every 7–10 days), each treat-
ment consisting of 1200 shocks with a frequency of
120 shocks/min; the energy density used varied from
0.03 to 0.4 mJ/mm2 and the control group (group 2)
went through the identical process but energy density
was simulated (0 mJ/mm2). The results revealed
significant reduction of pain in the shockwave group
(group 1). In the control group (group 2) no significant
decrease of VAS was seen.
Wang, Wang, Yang, Weng, Ko [30] evaluated
patients with an established diagnosis of chronic
plantar fasciitis, including patients in the shockwave
treatment group and patients in the control group. In
the shockwave group, patients received 1500
Table 2. The analgesic effects of ESWT
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impulses of shockwaves at 16 kV to the affected
heel in a single session. Patients in the control group
received CT consisting of orthotics, physical therapy,
an exercise program, and/or a local cortisone
injection. Before treatment, groups showed no
significant differences in the scores for pain. After
treatment, the shockwave group showed significantly
better pain scores in comparison with the control
group. The overall results were 69.1 % excellent,
13.6 % good, 6.2 % fair, and 11.1 % poor for the
shockwave group and 0 % excellent, 55 % good,
36 % fair, and 9 % poor for the control group.
Our study confirmed the results of other authors.
The doses used in ESWT gradually decreased pain
intensity in  the shockwave group (group 1) and this
trend persisted up to 6 months from the last session
of ESWT. The observed differences in this period
were statistically significant. In the control group
(group 2) no significant decrease of VAS was seen
after the treatment and in the period from 3 months
to 6 months after the end of CT and in the period
from 3 months to 6 months after the end of CT in
patients with HS. Furthermore,  statistically significant
differences in pain were  also found  between the
two groups. Excellent improvement of pain intensity
was seen in 73.3 % patients, good improvement was
seen in  20 % patients and slight improvement was
seen  in 6.7 % patients in the shockwave group
(group 1) at three reference points: at rest, when
walking on awakening, and after normal daily activity.
As for the control group (group 1), there was no
reduction of pain intensity; it remained unchanged
in 80 % of patients  and worsened in 20 % of patients
at these points. Summing up, the results of short-
term studies show that ESWT effectively reduces
pain, which, in turn, reduces mental and physical
discomfort in patients with chronic HS.
Conclusion
The short-term studies have demonstrated the
analgesic effectiveness of ESWT. We achieved a
significant reduction of pain, that persisted for 6
months in shockwaves group. ESWT reduces pain
more effectively than CT in males with chronic HS.
The studies have shown that ESWT is a repeatable
and non-invasive treatment, and, therefore, is a
valuable alternative therapeutic option for surgical
treatment and other CT in patients suffering from
pain due to chronic HS.
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